{"id":"phx1149t","safety":{"commonSideEffects":[{"rate":null,"effect":"unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the molecular target, which leads to a specific therapeutic effect.","oneSentence":"PHX1149T is a small molecule that targets the molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:49:16.027Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"unknown"}]},"trialDetails":[{"nctId":"NCT00998686","phase":"PHASE3","title":"Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin","status":"TERMINATED","sponsor":"Phenomix","startDate":"2009-11","conditions":"Type 2 Diabetes Mellitus","enrollment":650},{"nctId":"NCT00865592","phase":"PHASE3","title":"Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Phenomix","startDate":"2009-03","conditions":"Type 2 Diabetes Mellitus, Type 2 Diabetes","enrollment":450},{"nctId":"NCT00850239","phase":"PHASE3","title":"Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin","status":"TERMINATED","sponsor":"Phenomix","startDate":"2009-05","conditions":"Type 2 Diabetes Mellitus","enrollment":700},{"nctId":"NCT01101945","phase":"PHASE2","title":"Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Phenomix","startDate":"2007-07","conditions":"Type 2 Diabetes Mellitus","enrollment":339},{"nctId":"NCT00690638","phase":"PHASE3","title":"Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Phenomix","startDate":"2008-07","conditions":"Type 2 Diabetes Mellitus","enrollment":480},{"nctId":"NCT00482950","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus","status":"UNKNOWN","sponsor":"Phenomix","startDate":"2007-04","conditions":"Type 2 Diabetes Mellitus","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["dutogliptin"],"phase":"phase_3","status":"active","brandName":"PHX1149T","genericName":"PHX1149T","companyName":"Phenomix","companyId":"phenomix","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PHX1149T is a small molecule that targets the molecular target. Used for unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}